What CDC is Doing
CDC thoroughly investigates every suspected AFM patient reported by health departments. We are looking at possible risk factors and causes, why some people develop this condition, monitoring AFM activity nationwide, and updating possible treatment options.
CDC focuses on
- enhancing surveillance for AFM so that all cases are identified and reported to CDC
- describing the clinical characteristics of patients with AFM, including their symptoms, test results, treatments received, and outcomes
- identifying the viruses that cause AFM
- improving strategies for communicating with and educating clinicians and parents
To learn about participating in AFM Research, visit How to Get Involved in Research
Supporting Health Departments
CDC provides guidance and tools for health departments for reporting AFM cases. We also support states that want to confirm their own cases by providing standard operating procedures, a medical chart abstraction tool, and training on how to interpret the information.
CDC collaborates with health departments and partners to educate clinicians so they are aware of the symptoms of AFM, how to report suspected cases of AFM, what specimens to collect, and the clinical guidance for patients with AFM. Educational activities and materials include health alerts, job aids, toolkits, webinars, and scientific publications and presentations. Learn more.
Communicating with Parents
CDC collaborates with a group of parents who offer support to children with AFM and their families. Together, we are working to raise awareness about AFM and share information and resources.
Providing Treatment Considerations
CDC and experts in a range of disciplines developed clinical guidance for the acute medical treatment of AFM of patients with AFM. We are continuing to explore and update these as more is discovered about AFM.
The AFM Task Force
The Acute Flaccid Myelitis Task Force is a nationwide group of physicians, scientists, and public health experts from a variety of disciplines and institutions. The Task Force is committed to moving the AFM research agenda forward to better understand the causes of AFM, and review and update clinical guidance on the management of patients with AFM.